Where Sabra Health Care REIT Stands With Analysts
Portfolio Pulse from Benzinga Insights
Sabra Health Care REIT (NASDAQ:SBRA) has received one bullish rating and three indifferent ratings from analysts in the last quarter. The average 12-month price target for the stock, according to four analysts, is $13.62, with a high of $15.00 and a low of $12.50. This average price target has increased by 23.82% over the past month.
September 20, 2023 | 9:00 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Sabra Health Care REIT has received mixed ratings from analysts, with a bullish outlook and an increased price target.
The bullish rating and increased price target indicate a positive outlook for Sabra Health Care REIT. However, the presence of indifferent ratings suggests some uncertainty among analysts.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100